ProPhase Labs Inc (PRPH)
5.16
+0.55
(+11.93%)
USD |
NASDAQ |
May 01, 16:00
5.15
-0.01
(-0.19%)
Pre-Market: 20:00
ProPhase Labs Cash from Investing (TTM): -1.369M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -1.369M |
September 30, 2023 | -5.108M |
June 30, 2023 | -6.11M |
March 31, 2023 | -7.813M |
December 31, 2022 | -2.077M |
September 30, 2022 | 8.41M |
June 30, 2022 | 5.708M |
March 31, 2022 | -8.75M |
December 31, 2021 | -19.67M |
September 30, 2021 | -22.49M |
June 30, 2021 | -20.24M |
March 31, 2021 | -7.826M |
December 31, 2020 | -1.016M |
September 30, 2020 | -0.887M |
June 30, 2020 | 1.041M |
March 31, 2020 | 3.099M |
December 31, 2019 | 5.543M |
September 30, 2019 | 2.822M |
June 30, 2019 | 1.919M |
March 31, 2019 | 13.90M |
December 31, 2018 | 11.86M |
September 30, 2018 | 16.62M |
June 30, 2018 | -7.028M |
March 31, 2018 | -18.63M |
December 31, 2017 | 21.77M |
Date | Value |
---|---|
September 30, 2017 | 16.72M |
June 30, 2017 | 40.37M |
March 31, 2017 | 40.34M |
December 31, 2016 | -0.651M |
September 30, 2016 | -0.459M |
June 30, 2016 | -0.617M |
March 31, 2016 | -0.882M |
December 31, 2015 | -0.709M |
September 30, 2015 | -0.859M |
June 30, 2015 | -0.647M |
March 31, 2015 | -0.326M |
December 31, 2014 | -0.306M |
September 30, 2014 | -0.234M |
June 30, 2014 | -0.27M |
March 31, 2014 | -0.451M |
December 31, 2013 | -0.442M |
September 30, 2013 | -0.301M |
June 30, 2013 | -0.328M |
March 31, 2013 | -0.27M |
December 31, 2012 | -0.31M |
September 30, 2012 | -0.345M |
June 30, 2012 | -0.328M |
March 31, 2012 | -0.338M |
December 31, 2011 | -0.134M |
September 30, 2011 | -0.129M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-22.49M
Minimum
Sep 2021
8.41M
Maximum
Sep 2022
-3.938M
Average
-1.369M
Median
Dec 2023
Cash from Investing (TTM) Benchmarks
Fonar Corp | -3.114M |
XWELL Inc | 5.65M |
Applied DNA Sciences Inc | -1.141M |
Veracyte Inc | 15.11M |
OncoCyte Corp | -0.932M |